Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
4.45    -0.05 (-1.11%)
Bid:
4.45
Ask:
4.60
Spread: 0.15 (3.371%)
Market Cap: £38.70m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

Related party transactions

23 Sep 2024 07:00

RNS Number : 1320F
Revolution Beauty Group PLC
23 September 2024
 

For immediate release

23 September 2024

Revolution Beauty Group plc

("Revolution Beauty", the "Group", or the "Company")

Related party transactions

 

Revolution Beauty (AIM: REVB), announces that it has agreed to manufacture and supply beauty and personal care products via its manufacturing subsidiary, Revolution Beauty QB Ltd ("Revolution Labs"), for Carbon Theory Limited and Delhicious Ltd, companies in which Adam Minto has an equity interest (the "AM Companies").

The aggregate value of the revenue and profits before tax to be generated in the current financial year by Revolution Labs from sales to the AM Companies amounts to approximately £530,000 and £50,000, respectively. The pricing for the products to be sold have been agreed on an arm's length basis, benchmarked against similar transactions, with equivalent terms as other third party customers of Revolution Labs. The transactions will be settled in cash according to Revolution Labs' normal credit terms and details will be disclosed in the financial statements of the Group for the relevant period, being the current financial year.

The supply of products to the AM Companies constitute related party transactions under Rule 13 of the AIM Rules by virtue of the AM Companies being associates of Adam Minto, a substantial shareholder of Revolution Beauty, as defined in the AIM Rules, holding approximately 15.34% of the ordinary shares in the Company. The directors of Revolution Beauty consider, having consulted with the Company's nominated adviser, Panmure Liberum Capital Limited, that the terms of the related party transactions are fair and reasonable insofar as shareholders of Revolution Beauty are concerned.

 

For further information, please contact:

 

Investor Relations

Lauren Brindley, CEO

Neil Catto, CFO

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

Panmure Liberum Capital Limited (NOMAD): Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222

 

Zeus: Nick Cowles / Jamie Peel / Jordan Warburton

Tel: +44 (0) 161 831 1512

 

Media enquiries

Headland Consultancy: Matt Denham / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDGGDCCXDDGSG
Date   Source Headline
26th Jan 20247:00 amRNSBlock Admission Application
24th Jan 20247:00 amRNSNotice of Capital Markets Event
13th Dec 20237:00 amRNSDirectorate changes and settlement agreement
8th Dec 20237:00 amRNSChange of Adviser & Rule 17 Schedule Two(g) Update
27th Nov 20237:00 amRNSPress speculation
22nd Nov 20237:18 amRNSHolding(s) in Company
14th Nov 20231:29 pmRNSHolding(s) in Company
14th Nov 20231:25 pmRNSHolding(s) in Company
14th Nov 20231:23 pmRNSHolding(s) in Company
14th Nov 20237:00 amRNSInterim Results
9th Nov 20231:21 pmRNSNotice of Interim Results
31st Oct 20236:08 pmRNSHolding(s) in Company
31st Oct 20236:07 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSResults of AGM
19th Sep 20237:00 amRNSGrant of Share Options
13th Sep 20232:44 pmRNSHolding(s) in Company
5th Sep 20237:00 amRNSNotice of AGM and posting of Annual Report
4th Sep 20235:30 pmRNSHolding(s) in Company
4th Sep 20235:27 pmRNSHolding(s) in Company
31st Aug 20238:32 amRNSDirectorate Changes
31st Aug 20238:30 amRNSFINAL RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2023
21st Aug 20237:00 amRNSNotice of Results
7th Aug 202312:45 pmRNSGeneral Meeting Indefinitely Adjourned
24th Jul 20234:22 pmRNSHolding(s) in Company
21st Jul 20234:57 pmRNSRegulatory Investigation
21st Jul 20231:43 pmRNSPDMR Dealing
21st Jul 202310:58 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSWithdrawal of GM requisition & Board Updates
18th Jul 20237:00 amRNSSettlement Agreement with boohoo
10th Jul 20234:49 pmRNSNotice of General Meeting
5th Jul 202310:37 amRNSChange of registered office address
4th Jul 20232:09 pmRNSDirector dealings
3rd Jul 20234:30 pmRNSDirector dealings
30th Jun 20237:00 amRNSResponse to boohoo
29th Jun 20237:00 amRNSDirector dealings
28th Jun 20237:30 amRNSRestoration - Revolution Beauty Group Plc
28th Jun 20237:00 amRNSRestoration of Trading
27th Jun 20236:15 pmRNSResult of AGM, directors, AIM update & requisition
23rd Jun 20238:02 amRNSTrading Update & response to boohoo Group REPLACE
23rd Jun 20237:00 amRNSTrading Update and response to boohoo Group plc
21st Jun 20237:00 amRNSHostile Shareholder Actions and AGM
20th Jun 20237:00 amRNSPotential legal proceedings
19th Jun 20233:29 pmRNSReceipt of Requisition Notice
2nd Jun 20237:00 amRNSNotice of AGM and posting of Annual Report
2nd Jun 20237:00 amRNSInterim Results
26th May 20237:00 amRNSFull year results 2022
25th May 20237:00 amRNSBoard Changes
28th Apr 20234:21 pmRNSFurther update on timing of FY22 Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.